Ribonucleic acid | CAS:63231-63-0

We serve Ribonucleic acid CAS:63231-63-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Ribonucleic acid

Chemical Name:Ribonucleic acid
CAS.NO:63231-63-0
Synonyms:Ribonucleic acid
RNA
 
Description:
Appearance:Light yellow to yellow powder
Assay:≥90.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Use:1, the application can improve the cellular immune function in health food and the immune adjustment ability, promote cell regeneration and repair.
2, nucleic acids and derivatives can promote crop growth, improve crop quality, enhance plant resistance.
3, treatment of disease such as coronary heart disease, tumor, myocardial infarction, drug raw materials, synthetic anticancer drug precursor.



Contact us for information like Nicotinamide riboside chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,RNA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nicotinamide riboside chloride Use and application,Pyridinium, 3-​(aminocarbonyl)​-​1-​β-​D-​ribofuranosyl-​, chloride (1:1) technical grade,usp/ep/jp grade.


Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.4-trifluoromethylbenzoic acid manufacturer This followed a declaration Thursday by the World Health Organization that the coronavirus outbreak is a Public Health Emergency of International Concern.N-(biphenyl-4-yl)-N-(4'-broMobiphenyl-4-yl)-9,9-diMethyl-9H-fluoren-2-amine supplier Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.Pigment Red 176 vendor Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.